Summer Intern- Analytical Sciences jobs in United States
cer-icon
Apply on Employer Site
company-logo

Rocket Pharmaceuticals · 8 hours ago

Summer Intern- Analytical Sciences

Rocket Pharmaceuticals is a fully integrated biotechnology company focused on advancing gene therapies for rare diseases. They are offering a paid summer internship for university students to gain hands-on experience in analytical sciences, specifically supporting assay development for gene and cell therapy programs.

BiotechnologyGeneticsHealth CarePharmaceutical
check
H1B Sponsor Likelynote

Responsibilities

Support real-time PCR, HPLC/UPLC and CE assays
Maintain accurate and detailed laboratory notebooks in a timely fashion
Collaborate with others in the laboratory to ensure smooth operation

Qualification

Real-time PCRLiquid chromatographyCapillary electrophoresisLaboratory experienceMS Office proficiencySense of urgencySelf-starterCollaboration skills

Required

Undergraduate rising junior or senior BS student with > 6 months laboratory experience
Understanding of real-time PCR, liquid chromatography and capillary electrophoresis assays
Self-starter and must function well under minimal supervision
Proficient in MS Office skills with a specific focus on word processing, formatting, tables, spreadsheets, presentations, graphics, slides, and templates, in addition to Adobe Acrobat
Handle issues appropriately and with a sense of urgency

Company

Rocket Pharmaceuticals

twittertwittertwitter
company-logo
Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.

H1B Sponsorship

Rocket Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (1)
2023 (2)
2022 (1)
2020 (1)

Funding

Current Stage
Public Company
Total Funding
$891.36M
Key Investors
RTW InvestmentsCalifornia Institute for Regenerative Medicine
2023-09-12Post Ipo Equity· $175M
2022-10-03Post Ipo Equity· $100.3M
2021-08-30Post Ipo Equity· $26.4M

Leadership Team

leader-logo
Gaurav Shah
CEO and President
linkedin
leader-logo
Jonathan Schwartz
Chief Scientific and Gene Therapy Officer
linkedin
Company data provided by crunchbase